Recombinant Methanococcus aeolicus Diphthine synthase (dphB)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. If you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchase method and location. Please consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing it.
Synonyms
dphB; Maeo_0435Diphthine synthase; EC 2.1.1.98; Diphthamide biosynthesis methyltransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-257
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Methanococcus aeolicus (strain ATCC BAA-1280 / DSM 17508 / OCM 812 / Nankai-3)
Target Names
dphB
Target Protein Sequence
MIILAGLGLY DEKDTTLKTV EFAKKADKIY AEFYTAILTG TTIEKIEETL GKEITILDRE KVELETEKLI NESKDKDIMF LTAGDPMVAT THIDIAIEAK KKGIEVIILN APSIYSAIGI TGLQLYKFGK TTSIVFPEPN YFPETPYDVI KENSKMGYHT LCLLDIQAHN TRFMTANEGL EVLLKIEEKR NENILNKDTK VVVVARAGSL KPKMVYGKIG DLLEYDFGAP LHCIIFTGNL HFMEEDALKY LCENISE
Uniprot No.

Target Background

Function
S-adenosyl-L-methionine-dependent methyltransferase that catalyzes the trimethylation of a modified histidine residue in translation elongation factor 2 (EF-2) to form diphthine. This three-step methylation is the second step in diphthamide biosynthesis.
Database Links
Protein Families
Diphthine synthase family

Q&A

What is Diphthine synthase and what is its role in cellular metabolism?

Diphthine synthase (dphB) is a methyltransferase enzyme (EC 2.1.1.98) that catalyzes a critical step in diphthamide biosynthesis. It functions by transferring a methyl group to an intermediate in the diphthamide biosynthetic pathway. In Methanococcus aeolicus, this enzyme is encoded by the dphB gene and has been characterized as part of the organism's 1.68 megabase circular chromosome containing 1,615 protein-coding genes . Functionally, dphB is classified as a diphthamide biosynthesis methyltransferase .

The enzyme plays a crucial role in the post-translational modification of elongation factor 2 (EF2), which is essential for protein synthesis. This modification protects cells from ADP-ribosylation by bacterial toxins such as diphtheria toxin and pseudomonas exotoxin A. The biochemical pathway involving dphB is conserved across archaeal species, making it an excellent model for studying evolutionary conservation of essential cellular processes.

How is Recombinant Methanococcus aeolicus Diphthine synthase (dphB) typically expressed and purified?

Recombinant Methanococcus aeolicus dphB is typically expressed in E. coli expression systems . The full-length protein (amino acids 1-257) is cloned into appropriate expression vectors and transformed into E. coli host strains such as ER2683 or other strains optimized for archaeal protein expression . The expression construct typically includes appropriate tags to facilitate purification, though tag type may vary based on experimental requirements .

A typical purification protocol involves:

  • Cell lysis using mechanical disruption or chemical methods

  • Initial purification using affinity chromatography based on the tag present

  • Secondary purification using ion exchange or size exclusion chromatography

  • Quality assessment using SDS-PAGE to confirm >85% purity

  • Optional mass spectrometry analysis to verify protein identity

For protein characterization, MS/MS spectra analysis using tools like PEAKS Studio Xpro with search parameters including fixed carbamidomethyl modification on cysteines and variable oxidation of methionine is recommended. Peptide identification should be filtered at 1% false discovery rate with at least two unique peptides per protein .

What are the optimal storage conditions for Recombinant Methanococcus aeolicus Diphthine synthase?

Optimal storage conditions for maintaining the stability and activity of Recombinant Methanococcus aeolicus Diphthine synthase include:

  • Short-term storage (up to one week): 4°C in appropriate buffer

  • Long-term storage: -20°C, with extended storage at -80°C recommended

  • Reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Addition of glycerol to a final concentration of 5-50% (optimally 50%) to prevent freeze-thaw damage

It is crucial to avoid repeated freeze-thaw cycles, which can significantly decrease enzymatic activity. Creating multiple working aliquots during initial reconstitution is strongly recommended. The shelf life of the liquid preparation is approximately 6 months at -20°C/-80°C, while lyophilized preparations can maintain stability for up to 12 months when stored properly .

Storage FormTemperatureMaximum Shelf LifeSpecial Considerations
Liquid4°C1 weekWorking aliquots only
Liquid with 50% glycerol-20°C6 monthsAvoid freeze-thaw cycles
Liquid with 50% glycerol-80°C6 monthsPreferred for long-term storage
Lyophilized-20°C/-80°C12 monthsReconstitute carefully

How can I design experiments to study the enzymatic activity of Diphthine synthase?

Designing rigorous experiments to study dphB enzymatic activity requires careful consideration of several factors:

Substrate Preparation: The natural substrate for dphB is an EF2 intermediate in the diphthamide biosynthesis pathway. For in vitro studies, researchers should either:

  • Use purified EF2 with the appropriate precursor modification

  • Develop synthetic peptide substrates containing the target modification site

Activity Assay Design:

  • Methyltransferase activity can be measured using:

    • Radiometric assays with [³H]-S-adenosyl methionine (SAM) as methyl donor

    • Fluorescence-based methyltransferase assays using SAM analogs

    • Coupled enzymatic assays that detect S-adenosyl homocysteine (SAH) production

  • Reaction conditions should include:

    • Buffer: Typically HEPES or Tris at pH 7.5-8.0

    • Cofactors: SAM (methyl donor), potential requirement for divalent cations

    • Temperature: 30-37°C (variable based on archaeal source)

Controls and Validation:

  • Include enzyme-free and substrate-free controls

  • Use known methyltransferase inhibitors as negative controls

  • Verify product formation using mass spectrometry

  • Consider site-directed mutagenesis of key catalytic residues to validate specificity

When designing these experiments, researchers should adopt approaches similar to those used for restriction-modification systems in M. aeolicus , adapting the methodology to focus specifically on methyltransferase activity rather than restriction enzyme activity.

What approaches are used to study the structure-function relationship of Diphthine synthase?

Multiple complementary approaches are utilized to elucidate the structure-function relationship of dphB:

Computational Structure Prediction:

  • Structure prediction using AlphaFold2 (ColabFold implementation) to generate models of dphB

  • Comparative analysis using DALI server to identify structural similarities with characterized methyltransferases

  • Identification of the SAM-binding domain and substrate recognition regions

Experimental Structure Determination:

  • X-ray crystallography of purified dphB (typically requiring >95% purity)

  • Protein NMR for dynamic regions or in complex with substrates

  • Cryo-EM for larger complexes involving dphB and interaction partners

Functional Mapping:

  • Site-directed mutagenesis of predicted catalytic residues

  • Chimeric protein construction between homologous dphB enzymes

  • Domain swapping experiments to identify functional domains

  • Hydrogen-deuterium exchange mass spectrometry to identify flexible regions

Protein-Substrate Interactions:

  • Surface plasmon resonance (SPR) to measure binding kinetics

  • Isothermal titration calorimetry (ITC) for thermodynamic binding parameters

  • Cross-linking mass spectrometry to identify interaction interfaces

These approaches should be integrated with structural information from related methyltransferases, similar to the homology-based searches performed for M. aeolicus methyltransferases using Seqware and HMMer tools .

How does Methanococcus aeolicus Diphthine synthase compare to homologs from other archaeal species?

Comparative analysis of dphB across archaeal species reveals important insights about conservation and specialization:

Sequence Conservation:
M. aeolicus dphB belongs to a family of conserved methyltransferases found across archaeal species. Sequence alignment shows:

  • Highly conserved SAM-binding motifs characteristic of class I methyltransferases

  • Variable regions that likely account for substrate specificity differences

  • Conservation patterns that follow phylogenetic relationships within the Euryarchaeal lineage

Structural Comparison:

  • The core methyltransferase fold is preserved across species

  • Differences in substrate binding regions reflect adaptation to species-specific EF2 sequences

  • Insertions/deletions in loop regions that may impact catalytic efficiency

Functional Differences:

  • Temperature optima correlate with the native growth conditions of source organisms

  • Kinetic parameters (Km, kcat) vary based on physiological requirements

  • Substrate specificity may differ slightly between homologs

Evolutionary Context:
M. aeolicus dphB should be analyzed within the context of the five restriction-modification systems identified in this organism . This comparative approach provides insights into the evolution of methyltransferases in the Methanococcales branch of Euryarchaeota and how these systems may have been horizontally transferred during evolution.

SpeciesSequence Identity to M. aeolicus dphBTemperature OptimumNotable Structural Features
M. aeolicus100%30-37°CReference structure
M. jannaschii~70-85% (estimated)45-55°CThermostable adaptations
M. maripaludis~60-80% (estimated)35-40°CSimilar core architecture
Methanosarcina species~40-60% (estimated)30-40°CMore divergent substrate binding

What expression systems yield the highest activity for Recombinant Methanococcus aeolicus Diphthine synthase?

Several expression systems can be employed for recombinant dphB production, each with advantages and limitations:

E. coli Expression Systems:
The most commonly used approach for M. aeolicus dphB expression is E. coli , with several specific strategies:

  • Host strain selection:

    • BL21(DE3) derivatives for T7-based expression

    • ER2683 for testing methyltransferase activity

    • ER2796 (methylation deficient) for avoiding host methylation interference

  • Vector selection:

    • pUC19 (high copy number) - useful for protein production but potentially toxic

    • pBR322 (medium copy number) - balanced expression

    • pACYC184 (low copy number) - reduces toxicity issues

  • Promoter selection:

    • T7 promoter for high-level controlled expression

    • Plac and Ptet alternatives when native archaeal promoters may not function in E. coli

Alternative Expression Systems:

  • Archaeal expression hosts (e.g., Methanococcus maripaludis) for native folding

  • Cell-free expression systems for proteins toxic to host cells

  • Yeast expression for specific post-translational modifications

Optimization Strategies:

  • Codon optimization for E. coli expression

  • Fusion tags (His, GST, MBP) to improve solubility

  • Co-expression with archaeal chaperones

  • Lower induction temperatures (16-25°C) to improve folding

The selection between these approaches should be guided by the intended application. For structural studies requiring high purity, E. coli expression with appropriate solubility tags is recommended. For functional studies where native activity is paramount, archaeal hosts or cell-free systems may be preferable despite lower yields.

How can I assess the purity and activity of recombinant dphB preparations?

Comprehensive quality assessment of recombinant dphB preparations involves multiple analytical methods:

Purity Assessment:

  • SDS-PAGE with Coomassie staining - target >85% purity

  • Western blotting with anti-dphB or anti-tag antibodies

  • Size exclusion chromatography to detect aggregates

  • Mass spectrometry to confirm:

    • Protein identity by peptide mapping

    • Intact mass analysis to verify full-length protein

    • Contaminant analysis using proteomics approaches

Activity Assessment:

  • Methyltransferase activity assays:

    • SAM-dependent methyl transfer to appropriate substrates

    • Detection of reaction products by HPLC, mass spectrometry, or radiometric methods

  • Binding assays:

    • Thermal shift assays to verify cofactor binding

    • Isothermal titration calorimetry for binding constants

  • Structural integrity:

    • Circular dichroism to assess secondary structure

    • Dynamic light scattering to verify monodispersity

Validation Methods:

  • Comparison to reference standards

  • Dose-dependent activity measurements

  • Inhibition studies with known methyltransferase inhibitors

  • Mass spectrometry verification of methylated products

A comprehensive quality control protocol should establish acceptance criteria for each parameter, similar to the approaches used for recombinant expression of other M. aeolicus enzymes such as MaeIII restriction endonuclease .

What are the recommended buffer conditions for dphB enzymatic assays?

Optimal buffer conditions for dphB enzymatic assays should be determined empirically, but typical starting conditions include:

Core Buffer Components:

  • Buffer type: 50 mM HEPES or Tris-HCl

  • pH range: 7.5-8.5 (start with pH 8.0)

  • Ionic strength: 50-150 mM NaCl or KCl

  • Stabilizers: 1-5 mM DTT or β-mercaptoethanol

  • Cofactors: 0.1-1 mM S-adenosyl methionine (SAM)

Additional Components:

  • Divalent cations: 1-10 mM MgCl₂ (test requirement)

  • Glycerol: 5-10% to enhance stability

  • BSA: 0.1-0.5 mg/ml as a stabilizer

  • EDTA: 0.1-1 mM (if divalent cations are inhibitory)

Reaction Conditions:

  • Temperature: 30-37°C (reflecting mesophilic nature of M. aeolicus)

  • Reaction time: 15-60 minutes (establish linear range)

  • Enzyme concentration: 0.1-1 μM (titrate for optimal activity)

  • Substrate concentration: At least 5x Km (if known)

Buffer ComponentConcentration RangePurpose
HEPES/Tris-HCl50-100 mMpH control
NaCl/KCl50-150 mMIonic strength
MgCl₂1-10 mMPotential cofactor
DTT1-5 mMMaintaining reduced state
SAM0.1-1 mMMethyl donor
Glycerol5-10%Stability enhancement

When optimizing these conditions, a systematic approach testing one variable at a time is recommended. Begin with pH optimization, followed by ionic strength, divalent cation requirements, and finally, cofactor concentrations. Similar methyltransferase assay conditions used for characterizing other M. aeolicus methyltransferases like M.MaeIV and M.MaeV can serve as useful reference points .

How do I address issues with low enzymatic activity in recombinant dphB preparations?

Low enzymatic activity in recombinant dphB preparations can stem from multiple causes, each requiring specific troubleshooting approaches:

Expression and Purification Issues:

  • Improper protein folding

    • Solution: Try lower induction temperatures (16-20°C)

    • Alternative: Use molecular chaperones as co-expression partners

    • Validation: Analyze secondary structure by circular dichroism

  • Truncated or degraded protein

    • Solution: Add protease inhibitors during purification

    • Alternative: Modify purification protocol to reduce processing time

    • Validation: Verify intact mass by MS and analyze for degradation products

  • Inactive conformation due to tags

    • Solution: Compare activity with and without cleaved tags

    • Alternative: Test different tag positions (N- vs C-terminal)

    • Validation: Perform limited proteolysis to identify flexible regions

Assay Optimization:

  • Suboptimal buffer conditions

    • Solution: Systematically vary pH, salt, and potential cofactors

    • Alternative: Test buffers mimicking archaeal cytoplasmic conditions

    • Validation: Perform thermal shift assays to monitor protein stability

  • Inactive or inappropriate substrate

    • Solution: Verify substrate integrity by mass spectrometry

    • Alternative: Test synthetic substrate analogs with modifications

    • Validation: Use positive control enzymes that act on the same substrate

  • Missing cofactors or activators

    • Solution: Supplement with archaeal cellular extract

    • Alternative: Add potential protein partners from diphthamide synthesis pathway

    • Validation: Perform pull-down assays to identify interacting partners

Storage and Handling:

  • Activity loss during storage

    • Solution: Add stabilizers (e.g., glycerol, trehalose)

    • Alternative: Lyophilize with appropriate cryoprotectants

    • Validation: Monitor activity over time under different storage conditions

When troubleshooting, adopt a systematic approach similar to that used for other M. aeolicus enzymes, implementing controlled experimental designs with appropriate positive and negative controls .

What factors might lead to conflicting results when studying dphB-catalyzed reactions?

Several factors can contribute to conflicting or inconsistent results when studying dphB-catalyzed reactions:

Experimental Variation Sources:

  • Enzyme heterogeneity

    • Inconsistent post-translational modifications

    • Varying proportions of active/inactive conformations

    • Batch-to-batch variability in purification

    • Solution: Implement rigorous quality control for each preparation

  • Substrate complexity

    • Variable modification states of EF2 substrates

    • Differential accessibility of target sites

    • Contaminants in substrate preparations

    • Solution: Develop well-characterized synthetic substrates

  • Assay interference

    • SAM degradation during storage

    • Inhibitory components in buffer systems

    • Variable detector sensitivity in analytical methods

    • Solution: Include internal standards and validated controls

Methodological Considerations:

  • Kinetic vs. endpoint measurements

    • Differential product accumulation rates

    • Time-dependent inhibition phenomena

    • Solution: Perform full kinetic analyses rather than single timepoint measurements

  • Detection method limitations

    • Differential sensitivity of various detection platforms

    • Matrix effects in mass spectrometry

    • Background signals in fluorescence/radiometric assays

    • Solution: Cross-validate results using complementary detection methods

  • Data analysis variations

    • Different curve-fitting algorithms

    • Variable baseline correction approaches

    • Solution: Standardize analysis methods and openly share raw data

Biological Variability:

  • Substrate microheterogeneity from different sources

  • Species-specific differences in substrate recognition

  • Enzyme conformational dynamics

To address conflicting results, researchers should implement the research question approach described in result , carefully identifying information gaps and developing specific questions to systematically investigate the source of variation.

How can I validate that my observed effects are specific to dphB activity?

Validating the specificity of observed effects to dphB activity requires multiple complementary approaches:

Genetic Validation:

  • Site-directed mutagenesis of catalytic residues

    • Create catalytically inactive mutants (e.g., SAM binding site mutations)

    • Demonstrate loss of activity with the mutant enzyme

    • Show that other properties remain unchanged (folding, substrate binding)

  • Complementation studies

    • Express dphB in knockout/deficient systems

    • Demonstrate rescue of diphthamide formation

    • Show correlation between expression level and activity restoration

Biochemical Validation:

  • Inhibition studies

    • Use specific methyltransferase inhibitors

    • Demonstrate dose-dependent inhibition

    • Show correlation between inhibition of purified enzyme and cellular effects

  • Product authentication

    • Identify methylated products by mass spectrometry

    • Demonstrate correct regiochemistry of methylation

    • Quantify stoichiometry of methyl group transfer

Control Experiments:

  • Substrate specificity

    • Test activity with modified or mutated substrates

    • Demonstrate substrate structure-activity relationships

    • Show lack of activity with unrelated substrates

  • Related enzyme comparisons

    • Test homologous methyltransferases with similar substrates

    • Demonstrate unique catalytic properties of dphB

    • Identify distinguishing kinetic parameters

Validation ApproachKey ControlsExpected Outcome
Catalytic mutantsSAM binding site mutationsLoss of methyltransferase activity without loss of substrate binding
Inhibitor studiesS-adenosylhomocysteineCompetitive inhibition with SAM
Product analysisIsotopically labeled SAMSpecific mass shift in product corresponding to methyl transfer
Substrate specificityModified target residueAbolished or reduced activity

When designing validation experiments, follow the stepwise research question approach outlined in result , ensuring that each experiment addresses a specific aspect of dphB activity validation.

How is dphB being used to study diphthamide biosynthesis pathways?

Recombinant Methanococcus aeolicus dphB serves as a powerful tool for investigating diphthamide biosynthesis through several research avenues:

Pathway Reconstitution:
Researchers are using purified dphB along with other diphthamide biosynthesis enzymes to reconstitute the pathway in vitro. This approach enables:

  • Identification of intermediate structures in the pathway

  • Determination of reaction order and dependencies

  • Discovery of potential regulatory mechanisms

  • Elucidation of rate-limiting steps

Comparative Genomics:
The dphB gene from M. aeolicus provides a reference point for identifying homologs across domains of life. This facilitates:

  • Mapping the evolutionary history of diphthamide biosynthesis

  • Identifying domain-specific variations in the pathway

  • Discovering potential novel functions in different organisms

  • Understanding the co-evolution with translation machinery

Structural Biology Advances:
High-resolution structural studies of dphB are revealing:

  • Detailed catalytic mechanisms of methyl transfer

  • Structural basis for substrate recognition

  • Conformational changes during catalysis

  • Potential allosteric regulation sites

Physiological Significance:
Research using dphB is helping to address fundamental questions about diphthamide function:

  • Role in translation fidelity and efficiency

  • Protective mechanisms against bacterial toxins

  • Potential regulatory roles beyond translation

  • Links to cellular metabolism and stress responses

These studies build upon methodologies similar to those used for investigating restriction-modification systems in M. aeolicus , applying them to understand the broader context of post-translational modifications in archaeal translation systems.

What role does dphB play in understanding archaeal evolution and metabolism?

The study of dphB provides significant insights into archaeal evolution and metabolism in several key areas:

Archaeal Methyltransferase Evolution:
dphB belongs to a family of archaeal methyltransferases that includes those involved in restriction-modification systems . Comparative analysis reveals:

  • Evolutionary relationships between metabolic and defensive methyltransferases

  • Horizontal gene transfer patterns of methyltransferase genes

  • Selection pressures on methyltransferase specificity and activity

  • Adaptations to different environmental niches

Post-translational Modification Systems:
Archaeal diphthamide synthesis represents a conserved post-translational modification pathway:

  • Comparison with bacterial and eukaryotic diphthamide synthesis mechanisms

  • Identification of archaeal-specific pathway components

  • Understanding of how these modifications contribute to archaeal protein function

  • Insights into the minimal required components for functional translation

Methanogen Metabolism:
In methanogenic archaea like M. aeolicus, dphB research connects to broader metabolic networks:

  • Relationship between S-adenosylmethionine metabolism and methanogenesis

  • Integration of methyltransferase activity with carbon and energy metabolism

  • Potential regulatory roles of methylation in archaeal gene expression

  • Adaptive significance of diphthamide in methanogen physiology

Archaeal Genetic Systems:
dphB research contributes to our understanding of:

  • Gene expression regulation in archaea

  • Protein quality control systems

  • Stress response mechanisms

  • Phylogenetic relationships within the Euryarchaeal lineage

The study of M. aeolicus dphB should be viewed in the context of the organism's complete genome (1.68 megabase circular chromosome with 1,615 protein-coding genes) and its broader restriction-modification systems , providing insights into how specialized methyltransferases have evolved within archaeal metabolism.

How does research on Methanococcus aeolicus dphB contribute to our understanding of restriction-modification systems?

Although dphB itself is not directly part of a restriction-modification (RM) system, research on this methyltransferase from M. aeolicus provides valuable comparative insights:

Methyltransferase Structural Relationships:

  • dphB shares structural features with RM-associated methyltransferases

  • Comparative analysis reveals conserved SAM-binding domains

  • Structural differences highlight substrate specificity determinants

  • Similar protein folding suggests evolutionary relationships

Mechanistic Parallels:

  • Both dphB and RM methyltransferases catalyze SAM-dependent methyl transfer

  • Similar reaction mechanisms with different target specificities

  • Shared catalytic residues despite different biological functions

  • Potential for similar regulatory mechanisms

Genomic Context:
M. aeolicus contains five distinct RM systems alongside dphB , enabling:

  • Comparative analysis of genomic organization

  • Study of transcriptional regulation patterns

  • Investigation of potential functional interactions

  • Understanding of how organisms balance metabolic and defensive methylation

Methodological Advances:
Techniques developed for dphB can be applied to RM systems:

  • Expression and purification strategies for archaeal methyltransferases

  • Activity assay development for methyl transfer reactions

  • Structural characterization approaches

  • Substrate specificity analysis methods

Research approaches similar to those used for identifying the five RM systems in M. aeolicus (such as methylome sequencing, homology-based genome annotation, and recombinant gene expression) can be adapted to study dphB, creating a more comprehensive understanding of methyltransferase diversity and evolution in this archaeal species.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.